Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 631 results for "erbitux"

EGFR Inhibitor Fails to Improve Biliary Cancer Survival

Adding the EGFR inhibitor cetuximab ( Erbitux ) to standard-of-care chemotherapy for advanced biliary cancer failed to improve patient survival, according to a study published online May20 in the Lancet Oncology . This is the third study in a row ... Medscape, 1 month ago

4 images for erbitux

Pharma Letter, 3 weeks ago
OncLive, 3 weeks ago
Scottrade, 1 month ago
OncLive, 1 month ago
Scottrade

Alchemia Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux (CHIME Trial)

"The commencement of this clinical trial achieves another milestone in the clinical development of HA-Irinotecan as this study will be the first use of a HyACT drug within an antibody-containing regimen, which is the current and future standard of ...
 Noodls1 month ago ALCHEMIA : Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux ("CHIME" Trial)  4 Traders1 month ago Research and Markets: Antibodies in Oncology Drug Pipeline Analysis 2014: 313 Companies Plus Partners Developing 671 Antibody Drugs in 1619 Developmental Projects  Morningstar.com1 month ago Physician Views: Avastin to lose share as front-line therapy for first-line metastatic colorectal cancer?  FirstWord Pharma2 weeks ago
[x]  
Pharma Letter

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows30-06-2014

Merck Serono, the biotech subsidiary of Germany's Merck KGaA (MRK: DE), has released positive new clinical trial results comparing its cancer drug Erbitux (cetuximab) with Swiss drug major Roche's (ROG: SIX) blockbuster Avastin (bevacizumab). ...
 Pharma Letter3 weeks ago From biopsies to blood-based testing  Drug Discovery News2 weeks ago Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test  Individual.com1 month ago Merck and Sysmex collaborate to develop biomarker test for colorectal cancer  PredictWallStreet1 month ago
[x]  

ESMO: Erbitux No Help in Esophageal Ca (CME/CE)

Gastroenterology Published: Jul 2, 2014 | Updated: Jul 2, 2014 Reviewedby Zalman S. Agus, MD ; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania Survival in esophageal cancer did not improve with the addition of ...
 MedPage Today3 weeks ago

Chemotherapy Regimens paired with Avastin or Erbitux Extended Survival for Patients with Metastatic Colorectal Cancer

In a plenary session of the American Society of Clinical Oncology (ASCO) meeting in Chicago, researchers reported that treatment of metastatic colorectal cancer with Avastin® (bevacizumab) or Erbitux® (cetuximab) and standard chemotherapy (FOLFOX ...
 CancerConnect.com1 month ago ASCO: Chemo Plus Avastin or Erbitux Boosts Colorectal Ca Survival  MedPage Today1 month ago Top 8 lessons learned at ASCO 2014  Orthopedics Today4 weeks ago ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?  Benzinga.com1 month ago

CRYSTAL analysis shows clinical benefit of Erbitux in RAS wild-type mCRC patients

Merck Serono, the biopharmaceutical division of Merck, has announced new biomarker findings from a retrospective analysis of the completed Phase III study CRYSTAL that compared Erbitux® (cetuximab) plus FOLFIRI with FOLFIRI alone. The analysis ...
 Medical News Today2 months ago Merck Announces New Retrospective Analysis Shows Significant Clinical Benefit in Overall Survival for Metastatic Colorectal Cancer Patients with RAS Wild-Type Tumors Receiving Erbitux plus FOLFIRI  Korea IT Times2 months ago
[x]  

The Zacks Analyst Blog Highlights: Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and …

For Immediate Release Chicago, IL July 25, 2014 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
 Yahoo! Finance9 hours ago The Zacks Analyst Blog Highlights:Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and Pfizer  Street Sweeper9 hours ago THE ZACKS ANALYST BLOG HIGHLIGHTS : Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and Pfizer  4 Traders9 hours ago
[x]  

Merck Backs Commitment To Future Investments In Chinese Market - Quick Facts

German drugmaker Merck (MKGAY.PK) reaffirmed its commitment to investments in the Chinese market, strengthening a major pillar of its emerging markets growth strategy. This week, Merck's Executive Board met in Shanghai, a month before the ...
 RTTNews.com2 days ago MERCK KGAA : Strengthens Commitment to Chinese Growth Market  4 Traders2 days ago Merck Strengthens Commitment to Chinese Growth Market  Bionity.com18 hours ago Merck Committed to Companion Diagnostics  Medical Design Technology1 week ago
[x]  
RTTNews.com

Bristol-Myers Squibb's Q2 profit slips on higher R&D costs; Yervoy, Eliquis sales top estimates

Bristol-Myers Squibb's second-quarter net profit slipped 38 percent year-over-year to $333 million, hit by the sale of the company's share in a diabetes joint venture to AstraZeneca and higher R&D expenses. In addition, quarterly revenue slipped 4 ...
 FirstWord Pharma21 hours ago Bristol-Myers Tops Profit Estimates Despite Sales Decline  RTTNews.com1 day ago BRISTOL MYERS SQUIBB : -Myers Posts Lower Profit, Revenue -- Update  4 Traders1 day ago Bristol-Myers Posts Lower Profit, Revenue -- ...  ADVFN UK1 day ago

Roche Holding AG's (RHHBY) CEO Daniel O'Day on H1 2014 Results - Earnings Call Transcript

7:00 AM ET Operator Ladies and gentlemen, good morning or good afternoon. Welcome to the Roche Half Year Results 2014 Conference Call. I'm Stephanie, the Chorus Call operator. [Operator Instructions] And the conference is being recorded.
 Seeking Alpha23 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less